Title

Modify E. Coli with a H2 Histamine Blocker to Decrease Stomach Acid Levels​ in Gastroesophageal reflux disease (GERD)​

Authors

Tristana Foster, Longwood UniversityFollow

Document Type

Presentation

Publication Date

Fall 11-16-2022

Abstract

By genetically modifying E. Coli with an H2 histamine receptor antagonist and delivering the bacteria as a nanoparticle with probiotics within mice. There will be a decrease in stomach acid secretion thus causing lower acid levels. With lower acid levels in the stomach, there will be a decrease in GERD occurrences.

Comments

Dr. Amorette Barber, Biology 488

Recommended Citation

Foster, Tristana, "Modify E. Coli with a H2 Histamine Blocker to Decrease Stomach Acid Levels​ in Gastroesophageal reflux disease (GERD)​" (2022). Fall Student Showcase 3 Minute Presentation Competition. 4.
https://digitalcommons.longwood.edu/fall3mp/4